Phoenixville, PA, United States of America

Ming Qi

This inventor holds 1 USPTO granted patent and 21 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Qi. Retrieved from https://idiyas.com/inventor/ming-qi-nxux8586

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Ming Qi

Introduction

Ming Qi is an accomplished inventor based in Phoenixville, PA (US). He has made significant contributions to the field of medical treatments, particularly in addressing high-risk multiple myeloma. His innovative approaches have the potential to improve patient outcomes and advance cancer treatment methodologies.

Latest Patents

Ming Qi holds a patent for "Methods of treating high risk multiple myeloma." This patent discloses methods for treating subjects with high-risk multiple myeloma, achieving negative minimal residual disease status, and predicting the likelihood of relapse or disease progression in affected individuals. His work in this area is crucial for enhancing treatment strategies for patients facing this challenging condition. He has 1 patent to his name.

Career Highlights

Ming Qi is currently employed at Janssen Biotech, Inc., where he continues to develop innovative solutions in the medical field. His role at the company allows him to collaborate with other experts and contribute to groundbreaking research and development.

Collaborations

Ming Qi has worked alongside notable colleagues, including Christopher Chiu and Amy Sasser. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in their field.

Conclusion

Ming Qi's contributions to the treatment of high-risk multiple myeloma exemplify the impact of innovation in medicine. His patent and ongoing work at Janssen Biotech, Inc. highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…